Results 161 to 170 of about 50,906 (248)

Herpes Zoster of the Larynx: A Diagnostic and Therapeutic Challenge. [PDF]

open access: yesCureus
Nogueira N   +4 more
europepmc   +1 more source

Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery

open access: yesChemical Biology &Drug Design, Volume 108, Issue 1, July 2026.
A stepwise translational framework linking natural‐product discovery, computational prioritisation, experimental validation, lead optimisation and targeted delivery is proposed to advance antiviral design. ABSTRACT The COVID‐19 pandemic highlighted the role of rapid viral mutation and global connectivity in accelerating viral emergence and spread ...
Adedayo Ayodeji Lanrewaju   +3 more
wiley   +1 more source

MIDD Evidence to Support Drug Regulatory Decisions in China

open access: yesClinical and Translational Science, Volume 19, Issue 7, July 2026.
ABSTRACT The paper systematically reviews the technical guidelines for Model‐Informed Drug Development (MIDD) issued by China's Center for Drug Evaluation (CDE), analyzing typical application cases of innovative drugs approved both in China and internationally to evaluate MIDD's critical role in supporting drug development and regulatory decision ...
Lili Gao   +3 more
wiley   +1 more source

Epidemiology of herpes zoster at a tertiary care centre in Eastern India. [PDF]

open access: yesBioinformation
Biswas S   +4 more
europepmc   +1 more source

Digital Dermatology

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 7, Page e934-e952, July 2026.
SUMMARY Digital transformation is fundamentally reshaping dermatology, creating new opportunities in diagnostics, therapy, and healthcare organization. Large datasets combined with Artificial Intelligence (AI) enable more precise classification and prognosis, particularly through the analysis of clinical and dermoscopic imaging.
Lea Henkel   +17 more
wiley   +1 more source

Real‐World Use of Emicizumab in Patients With Acquired Haemophilia A: An Interim Safety Analysis of a Large‐Scale Post‑Marketing Surveillance Study

open access: yesHaemophilia, Volume 32, Issue 4, Page 933-942, July/August 2026.
ABSTRACT Introduction Acquired haemophilia A (AHA) is a rare autoimmune disorder where the development of autoantibodies to factor (F)VIII neutralise its function, leading to bleeding. Emicizumab has been approved for treating AHA in Japan. Aim This post‐marketing study was performed to primarily examine the use and safety of emicizumab, and indirectly
Midori Shima   +8 more
wiley   +1 more source

Feasibility and outcomes of kidney transplantation in patients with end‐stage kidney disease after haemopoietic stem cell transplantation

open access: yesInternal Medicine Journal, Volume 56, Issue 7, Page 1174-1181, July 2026.
Abstract Background Advances in haemopoietic stem cell transplantation (HSCT) have improved long‐term survival, but they have also led to late complications, such as nephropathy. However, the safety and feasibility of kidney transplantation (KT) in patients with HSCT‐related end‐stage kidney disease (ESKD) remain unclear.
Bioh Kim   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy